Summary
A case study is presented of a 44-year-old negroid male with epidermodysplasia verruciformis (EV), cutaneous carcinomas, and impaired cell-mediated immunity (CMI), infected with human papillomavirus type 8 and 17. Analysis was made of (a) T6+and HLA-DR+Langerhans cells (LCs) by immunoperoxidase staining in lesional and clinically normal skin before and during retinoid treatment, (b) the effect of retinoid treatment on CMI in vivo and in vitro, and (c) cytogenetic aspects related to chromosomal instability. The results showed the virtual absence of T6+and HLA-DR+LCs in koilocytic areas of epidermis involved with EV. Light-exposed, clinically normal skin also demonstrated microscopic EV lesions largely devoid of T6+and HLA-DR+LCs. Retinoid treatment with etretinate (Ro 10-9359) appeared both to increase the CMI response in vitro to T-cell mitogens and to influence the in situ pattern of T6+and HLA-DR+LCs. The cytogenetic study did not show evidence of spontaneous or UV-induced chromosomal instability.
Similar content being viewed by others
References
Androphy EJ, Dvoretzky I, Maluish AE, Wallace HJ, Lowy DR (1984) Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha-interferon. J Am Acad Dermatol 11:197–202
Androphy EJ, Dvoretzky I, Lowy DR (1985) X-linked inheritance of epidermodysplasia verruciformis. Arch Dermatol 121:864–868
Bagot M, Heslan M, Dubertret L, Roujeau JC, Touraine R, Levy JP (1985) Antigen-presenting properties of human epidermal cells compared with peripheral blood monnonuclear cells. Br J Dermatol 113 [Suppl 28]:55–60
Bauer R, Orfanos CE (1985) Effects of synthetic retinoids on human peripheral blood lymphocytes and polymorphonuclears in vitro. In: Cunliffe WJ, Miller AJ (eds) Retinoid therapy. MTP Press, Lancaster, pp 101–118
Bleumink E, Nater JP, Schraffordt Koops H, The TH (1974) A standard method for DNCB sensitization testing in patients with neoplasms. Cancer 33:911–915
Blitstein-Willinger E, Haas N, Nurnberger F, Stuttgen G (1986) Immunological findings during treatment of multiple keratoacanthoma with etretinate. Br J Dermatol 114:109–116
Chardonnet Y, Viac J, Thivolet J (1986) Langerhans cells in human warts. Br J Dermatol 115:669–675
Claudy AL, Touraine JL, Mitanne D (1982) Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Arch Dermatol Res 274:213–219
Craifemberghi S, Gavazzoni R, Coglio G, Pozzo G (1982) Epidermodisplasia verruciforme di Lewandowsky-Lutz. Giorn It Derm Venereol 117:191–194
Faure M, Dezutter-Dambuyant C, Schmitt D, Gaucherand M, Thivolet J (1985) Langerhans cell induced cytotoxic T-cell responses against normal human epidermal cell targets: in vitro studies. Br J Cermatol 113 [Suppl 28]:114–117
Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP (1985) Latent papillomavirus and recurrent genital warts. N Engl J Med 313:784–788
Gassenmaier A, Lammel M, Pfister H (1984) Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20 and 25 from a patient with epidermodysplasia verruciformis. J Virol 52:1019–1023
Giessen M van der, Postma S, The TH (1985) Isolation of highly purified lymphocyte subsets for functional studies by means of an indirect rosette technique. Scand J Immunol 22:41–49
Guilhou JJ, Malbos S, Barneon S, Habib A, Baldet P, Meynadier J (1980) Epidermodysplasie verruciforme. Etude immunologique. Ann Dermatol Venerol 107:611–619
Haftek M, Jablonska S, Orth G (1985) Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts. Dermatologica 170:213–220
Herberman RB (1984) Possible role of natural killer cells and other effector cells in immune surveillance against cancer. J Invest Dermatol 83:137s-140s
Jablonska S, Orth G, Lutzner MA (1982) Immunopathology of human papillomavirus-induced tumors in different tissues. Springer Semin Immunopathol 5:33–62
Jacyk WK, Lechner W (1984) Epidermodysplasia verruciformis in lepromatous leprosy. Dermatologica 168:202–205
Jacyk WK, Subbuswamy SG (1979) Epidermodysplasia verruciformis in Nigerians. Dermatologica 159:256–265
Jong MCJM de, Blanken R, Nanninga J, Voorst Vader PC van, Poppema S (1986) Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. J Invest Dermatol 87:698–702
Kallenberg CGM, Voort-Beelen JM van der, Amaro J de, The TH (1981) Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol 43:478–485
Kaminski M, Pawinska M, Jablonska S, Szmurlo A, Majewski S, Orth G (1985) Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Arch Dermatol 121:84–86
Kanerva LO, Johansson E, Niemi KM, Lauharanta J, Salo OP (1985) Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy. Arch Dermatol Res 278:153–160
Kienzler JL, Laurent R, Coppey J, Favre M, Orth G, Coupez L, Agache P (1979) Epidermodysplasie verruciforme. Ann Dermatol Venereol 106:549–563
Kraemer KH (1983) Heritable diseases with increased sensitivity to cellular injury. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Update: dermatology in general medicine. McGraw-Hill, New York, pp 113–140
Kremsdorf D, Favre M, Jablonska S, Obalek S, Rueda LA, Lutzner MA, Blanchet-Bardon C, Voorst Vader PC van, Orth G (1984) Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol 52:1013–1018
Lutzner MA, Blanchet-Bardon C, Orth G (1984) Clinical observations, virologic studies and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 83:18s-25s
Pfister H, Nurnberger F, Gissmann L, Hausen H zur (1981) Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-Volta. Int J Cancer 27:645–650
Proniewska M, Jablonska S (1980) UV-induced DNA repair synthesis in patients with epidermodysplasia verruciformis. Dermatologica 160:289–296
Scheres JMJC (1972) Identification of two Robertsonian translocations with a Giemsa banding technique. Hum Genet 15:253–256
Smeets DFCM, Scheres JMIC, Hustinx TWJ (1984) The fragile site on chromosome 3. Hum Genet 67:351
Steinberg BM, Topp WC, Schnieder PS, Abramson AL (1983) Laryngeal papillomavirus infection during clinical remission. N Engl J Med 308:1261–1264
Sutherland GR, Hecht F (1985) Fragile sites on human chromosomes. Oxford University Press, New York
Tanigaki T, Kanda R, Yutsudo M, Hakura A (1986) Human papillomavirus DNA detected in squamous-cell carcinoma tissue of a patient with epidermodysplasia verruciformis. Arch Dermatol Res 279:66–67
Verweij H, Voorst Vader PC van, Houthoff HJ, Gips CH (1985) Quantitative analysis of retinoids in human serum and tissue samples using high performance liquid chromatography. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Karger, Basel, pp 301–304
Voorst Vader PC van, Jaspers NGJ, Kamp AWM van der (1984) Retinoic acid and defective UV light induced DNA excision repair in xeroderma pigmentosum: absence of ameliorating effect. Arch Dermatol Res 276:201–202
Voorst Vader PC van, Orth G, Dutronquay V, Driessen LHHM, Eggink HF, Kallenberg CGM, The TH (1986) Epidermodysplasia verruciformis: skin carcinoma containing human papillomavirus type 5 DNA sequences and primary hepatocellular carcinoma associated with chronic hepatitis B virus infection in a patient. Acta Derm Venereol 66:231–236
Wojtulewicz-Kurkus J, Glinski W, Jablonska S, Podobinska I, Obalek S (1985) Identification of HLA antigens in familial and non-familial epidermodysplasia verruciformis. Dermatologica 170:53–58
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Voorst Vader, P.C., de Jong, M.C.J.M., Blanken, R. et al. Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics. Arch Dermatol Res 279, 366–373 (1987). https://doi.org/10.1007/BF00412621
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00412621